Clinical Trial Update: Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing the role of pioglitazone in treating non-alcoholic steatohepatitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Actos (pioglitazone) (pioglitazone)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Nonalcoholic Steatohepatitis | Phase 4 | Status: COMPLETED